TRUBRIDGE INC (TBRG) Stock Fundamental Analysis
USA - NASDAQ:TBRG - US2053061030 - Common Stock
21.79 USD
+0.38 (+1.77%)
21.79 USD
0 (0%)
Overall TBRG gets a fundamental rating of 4 out of 10. We evaluated TBRG against 35 industry peers in the Health Care Technology industry. There are concerns on the financial health of TBRG while its profitability can be described as average. TBRG is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
TBRG had positive earnings in the past year.
In the past year TBRG had a positive cash flow from operations.
In multiple years TBRG reported negative net income over the last 5 years.
Each year in the past 5 years TBRG had a positive operating cash flow.
1.2 Ratios
TBRG has a better Return On Assets (-2.41%) than 77.14% of its industry peers.
TBRG has a Return On Equity of -5.43%. This is in the better half of the industry: TBRG outperforms 77.14% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.32%, TBRG belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.41% | ||
| ROE | -5.43% | ||
| ROIC | 5.32% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 6.59%, TBRG is in the better half of the industry, outperforming 77.14% of the companies in the same industry.
In the last couple of years the Operating Margin of TBRG has declined.
With a Gross Margin value of 52.76%, TBRG perfoms like the industry average, outperforming 45.71% of the companies in the same industry.
In the last couple of years the Gross Margin of TBRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.59% | ||
| PM (TTM) | N/A | ||
| GM | 52.76% |
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TBRG is destroying value.
Compared to 1 year ago, TBRG has more shares outstanding
The number of shares outstanding for TBRG has been increased compared to 5 years ago.
TBRG has a better debt/assets ratio than last year.
2.2 Solvency
TBRG has an Altman-Z score of 2.05. This is not the best score and indicates that TBRG is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.05, TBRG is doing good in the industry, outperforming 65.71% of the companies in the same industry.
The Debt to FCF ratio of TBRG is 10.13, which is on the high side as it means it would take TBRG, 10.13 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.13, TBRG is in line with its industry, outperforming 51.43% of the companies in the same industry.
TBRG has a Debt/Equity ratio of 0.94. This is a neutral value indicating TBRG is somewhat dependend on debt financing.
The Debt to Equity ratio of TBRG (0.94) is worse than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.94 | ||
| Debt/FCF | 10.13 | ||
| Altman-Z | 2.05 |
ROIC/WACC0.53
WACC10.13%
2.3 Liquidity
A Current Ratio of 1.80 indicates that TBRG should not have too much problems paying its short term obligations.
The Current ratio of TBRG (1.80) is worse than 62.86% of its industry peers.
TBRG has a Quick Ratio of 1.79. This is a normal value and indicates that TBRG is financially healthy and should not expect problems in meeting its short term obligations.
TBRG has a Quick ratio of 1.79. This is in the lower half of the industry: TBRG underperforms 62.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.79 |
3. Growth
3.1 Past
TBRG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.21%.
TBRG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -40.46% yearly.
TBRG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.20%.
TBRG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.53% yearly.
EPS 1Y (TTM)-36.21%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%237.5%
Revenue 1Y (TTM)-17.2%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%1.18%
3.2 Future
TBRG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 132.46% yearly.
Based on estimates for the next years, TBRG will show a small growth in Revenue. The Revenue will grow by 3.80% on average per year.
EPS Next Y966.97%
EPS Next 2Y247.16%
EPS Next 3Y132.46%
EPS Next 5YN/A
Revenue Next Year3.3%
Revenue Next 2Y3.82%
Revenue Next 3Y3.8%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
TBRG is valuated quite expensively with a Price/Earnings ratio of 29.45.
TBRG's Price/Earnings ratio is rather cheap when compared to the industry. TBRG is cheaper than 82.86% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.38, TBRG is valued at the same level.
The Price/Forward Earnings ratio is 9.52, which indicates a very decent valuation of TBRG.
94.29% of the companies in the same industry are more expensive than TBRG, based on the Price/Forward Earnings ratio.
TBRG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.45 | ||
| Fwd PE | 9.52 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TBRG indicates a rather cheap valuation: TBRG is cheaper than 97.14% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, TBRG is valued cheaply inside the industry as 88.57% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.95 | ||
| EV/EBITDA | 9.67 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TBRG's earnings are expected to grow with 132.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y247.16%
EPS Next 3Y132.46%
5. Dividend
5.1 Amount
TBRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
21.79
+0.38 (+1.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners67.96%
Inst Owner Change0%
Ins Owners3.17%
Ins Owner Change-3.62%
Market Cap327.07M
Analysts78
Price Target25.25 (15.88%)
Short Float %6.09%
Short Ratio6.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.79%
Min EPS beat(2)20.66%
Max EPS beat(2)122.91%
EPS beat(4)2
Avg EPS beat(4)-29.99%
Min EPS beat(4)-176.25%
Max EPS beat(4)122.91%
EPS beat(8)5
Avg EPS beat(8)-12.21%
EPS beat(12)6
Avg EPS beat(12)-13.47%
EPS beat(16)8
Avg EPS beat(16)-8.87%
Revenue beat(2)0
Avg Revenue beat(2)-2.06%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-0.83%
Revenue beat(4)1
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)1.51%
Revenue beat(8)2
Avg Revenue beat(8)-1.27%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)5
Avg Revenue beat(16)-0.61%
PT rev (1m)-15.38%
PT rev (3m)-15.38%
EPS NQ rev (1m)16.12%
EPS NQ rev (3m)1.62%
EPS NY rev (1m)48.32%
EPS NY rev (3m)44.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.48%
Revenue NY rev (1m)-1.69%
Revenue NY rev (3m)-1.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.45 | ||
| Fwd PE | 9.52 | ||
| P/S | 0.94 | ||
| P/FCF | 19.95 | ||
| P/OCF | 9.37 | ||
| P/B | 1.89 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.67 |
EPS(TTM)0.74
EY3.4%
EPS(NY)2.29
Fwd EY10.51%
FCF(TTM)1.09
FCFY5.01%
OCF(TTM)2.33
OCFY10.68%
SpS23.16
BVpS11.54
TBVpS-7.55
PEG (NY)0.03
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.41% | ||
| ROE | -5.43% | ||
| ROCE | 6.74% | ||
| ROIC | 5.32% | ||
| ROICexc | 5.52% | ||
| ROICexgc | 43.92% | ||
| OM | 6.59% | ||
| PM (TTM) | N/A | ||
| GM | 52.76% | ||
| FCFM | 4.72% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-34.77%
ROICexcg growth 5Y-16.72%
ROICexc growth 3Y-36.47%
ROICexc growth 5Y-24.96%
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
F-Score7
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.94 | ||
| Debt/FCF | 10.13 | ||
| Debt/EBITDA | 3.32 | ||
| Cap/Depr | 70.69% | ||
| Cap/Sales | 5.33% | ||
| Interest Coverage | 1.58 | ||
| Cash Conversion | 71.1% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.79 | ||
| Altman-Z | 2.05 |
F-Score7
WACC10.13%
ROIC/WACC0.53
Cap/Depr(3y)79.13%
Cap/Depr(5y)69.66%
Cap/Sales(3y)6.13%
Cap/Sales(5y)4.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.21%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%237.5%
EPS Next Y966.97%
EPS Next 2Y247.16%
EPS Next 3Y132.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.2%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%1.18%
Revenue Next Year3.3%
Revenue Next 2Y3.82%
Revenue Next 3Y3.8%
Revenue Next 5YN/A
EBIT growth 1Y256.08%
EBIT growth 3Y-36.24%
EBIT growth 5Y-23.05%
EBIT Next Year149.44%
EBIT Next 3Y43.12%
EBIT Next 5YN/A
FCF growth 1Y2208.59%
FCF growth 3Y-29.73%
FCF growth 5Y-20.85%
OCF growth 1Y48.79%
OCF growth 3Y-12.4%
OCF growth 5Y-5.94%